Actavis, Inc. News Headlines

ACT 
$227.55
*  
0.57
0.25%
Get ACT Alerts
*Delayed - data as of Sep. 2, 2014 12:43 ET  -  Find a broker to begin trading ACT now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    ACT Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

3 Reasons Actavis plc Stock Could Rise
9/2/2014 11:39:52 AM - Motley Fool

Actavis Reports FDA Acceptance For Filing Of NDA For Eluxadoline - Quick Facts
9/2/2014 9:42:00 AM - RTT News

3 Reasons Teva Pharmaceutical Industries Ltd. Stock Could Rise
9/1/2014 7:56:11 PM - Motley Fool

Notable ETF Outflow Detected - SSO, ACE, ACT, ADT
8/29/2014 11:02:09 AM - BNK Invest

UCB Files Patent Infringement Lawsuit vs. Actavis - Analyst Blog
8/28/2014 4:40:00 PM - Zacks.com

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha

Supernus' Trokendi XR Faces Generic Threat from Actavis - Analyst Blog
8/22/2014 4:55:00 PM - Zacks.com

Actavis Confirms Patent Challenge For Generic Neupro
8/22/2014 4:17:00 PM - RTT News

Tracking Dan Loeb's Third Point Portfolio - Q2 2014 Update
8/22/2014 4:44:00 AM - Seeking Alpha

Actavis Up on Positive Phase III Ceftazidime-Avibactam Data - Analyst Blog
8/21/2014 4:30:00 PM - Zacks.com

Tenet Healthcare Is The Most Crowded Hedge Fund Position
8/21/2014 4:11:00 PM - Seeking Alpha

Sector Update: Health-Care Shares Higher Pre-Market
8/19/2014 8:30:47 AM - MT Newswires

Sector Update: Health Care
8/19/2014 8:26:09 AM - MT Newswires

Actavis Reports Positive Results From Ceftazidime-Avibacta Phase III Studies
8/19/2014 7:37:00 AM - RTT News

Tracking Carl Icahn's Portfolio - Q2 2014 Update
8/19/2014 12:17:00 AM - Seeking Alpha

Tracking John Paulson's Paulson & Company Portfolio - Q2 2014 Update
8/18/2014 8:09:00 AM - Seeking Alpha

Synergy Pharma (SGYP) Posts Wider-than-Expected Loss in Q2 - Analyst Blog
8/13/2014 3:03:00 PM - Zacks.com

Why Tax Inversions Won't Go Away
8/13/2014 2:20:00 PM - Seeking Alpha

InterMune Draws Bids from Sanofi, Roche, GlaxoSmithKline -Bloomberg
8/13/2014 1:57:00 PM - Dow Jones Business News

Lundbeck Remains A High-Risk/High-Reward Specialty Pharmaceutical Play
8/12/2014 1:29:00 PM - Seeking Alpha

12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds
8/10/2014 10:54:00 AM - Seeking Alpha

Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
8/5/2014 2:00:00 PM - Zacks.com

Ironwood Pharmaceuticals Narrows Q2 Loss, Revenues Down - Analyst Blog
8/5/2014 11:00:00 AM - Zacks.com

Sector Update: Health Care Stocks Weighed in Pre-Market Trade
8/5/2014 8:25:25 AM - MT Newswires

Sector Update: Health Care
8/5/2014 8:20:15 AM - MT Newswires